Welcome to the Institute for Cardiovascular Prevention (IPEK)
Discover our Research Labs
Meet our Team
Visit us
Visit us

The Institute for Cardiovascular Prevention is dedicated to understanding and ultimately treating cardiovascular disease. Our research encompasses a broad spectrum, from immune regulation in atherosclerosis to metabolic pathways, molecular inflammation, and neuroimmune interactions.

INSTITUTE DIRECTOR

LATEST NEWS & EVENTS

Pathogenic high affinity autoantibody in Artery Tertiary Lymphoid Organs in Atherosclerosis

7 Sep 2026 | News | Publication

NATURE CARDIOVASC RES ➤ IPEK scientists from the Habenicht Lab identify a a pathogenic high affinity autoantibody in atherosclerosis

Cannabinoid receptor identified as new target against atherosclerosis

22 Jul 2026 | News | Publication

NATURE COMM ➤IPEK scientists from the Steffens Lab show that cannabinoid receptor promotes the development of atherosclerosis in the blood vessels.

Insights from the GRC Chemotactic Cytokines Conference 2026

15 Jun 2026 | News | Conference

CONFERENCE HIGHLIGHT ➤ IPEK was well represented at the latest Gordon Research Conference (GRC) on Chemotactic Cytokines, held in Les Diablerets, Switzerland, from 7–12 June.

MORE NEWS & EVENTS

VISIT OUR LABS

Research Labs

Technology Labs

MEET OUR TEAM

About us

PUBLICATIONS
FUNDING
EDUCATION